Quest Diagnostics Inc Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain
Quest Diagnostics Inc (DGX) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain of $70.00 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2021-10-22.
Discontinued › Income Statement › Other Income
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain · last filed 2021-10-22
- 2020-09-30: Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 9 month $70.00M.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 9 month |
|---|---|
| 2020-09-30 | $70.00M 10-Q · filed 2021-10-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |